Agile Therapeutics, Inc.

NJ · United States · Reporting entity ID 100000921825

Total reported 2019–2025

$1.12M

#1,258 of 2,960 reporting companies — 0% of all reported industry payments

$1.09M in general payments across 26,546 records, plus $11K in research funding across 7 records.

How it breaks down

General payments $1,094,005

Research funding $10,931

Ownership & investment $19,956

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.